Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Annmarie Vilkins

Obstetrics & Gynecology Ann Arbor, MI Doctor of Osteopathy

NPI 1710320494 CMS profile 3532679

1500 East Medical Center Drive, 9Th Floor Vonvoigtlander Womens Hosp Recp B, Ann Arbor, MI 48109

Open in the dashboard

General payments

$68,701

99 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Annmarie Vilkins of Ann Arbor, MI is reported in the CMS Open Payments database as having received $68,701 across 99 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $37,183 53
2024 General $28,449 36
2023 General $291 3
2022 General $1,049 3
2021 General $114 2
2020 General $1,500 1
2019 General $115 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Annmarie Vilkins
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Annmarie Vilkins were reported at $37,183. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Annmarie Vilkins Obstetrics & Gynecology median Middle half National median
2019 $115 $172 $62–$391 $163
2020 $1,500 $94 $36–$222 $114
2021 $114 $136 $42–$369 $132
2022 $1,049 $160 $50–$433 $149
2023 $291 $169 $56–$423 $160
2024 $28,449 $152 $50–$371 $164
2025 $37,183 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $63,386 78 payments
  2. Intuitive Surgical, Inc. $1,958 9 payments
  3. AbbVie, Inc. $1,703 3 payments
  4. Applied Medical Resources Corporation $932 2 payments
  5. Gynesonics, Inc. $505 4 payments
  6. Medical Device Business Services, Inc. $117 1 payment
  7. Meditrina $74 1 payment
  8. Hologic, LLC $26 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $28,875 12 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $25,875 10 payments
  3. Travel and Lodging $10,127 42 payments
  4. Food and Beverage $2,824 34 payments
  5. Education $1,000 1 payment
Products named General payments · program years 2019–2025
  1. PICO $56,435 67 payments
  2. PICO 7 $9,859 5 payments
  3. PICO 14 $9,648 3 payments
  4. ALLEVYN HEEL 10.5CM X 13.5CM CTN 5 $5,647 4 payments
  5. ORILISSA $1,588 2 payments
  6. DAVINCI XI $1,000 1 payment
  7. Da Vinci Surgical System $958 8 payments
  8. GELPOINT V-PATH $905 1 payment
  9. ALLEVYN LIFE SACRUM (LARGE) PACK OF 10 $797 3 payments
  10. SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM $505 4 payments
  11. Other $168 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

38

Median for Obstetrics & Gynecology: 65

Drug cost

$1,286

Median for Obstetrics & Gynecology: $3,585

Branded share of claims

0%

Median for Obstetrics & Gynecology: 25.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Norethindrone Acetate Generic 21 $1,037
Cyclobenzaprine Hcl Generic 17 $249

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 20 billing codes

Paid by Medicare

$4,117

Medicare's payments for the services billed

Medicare patients

17

Average age 51

Services billed

29

17 women, 0 men among their patients

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

99 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record